Close
ACHEMA MIDDLE EAST 2026

New FDA Guidance To Enhance Diversity In Clinical Trials

The FDA has made progress in promoting diversity in clinical trials. Recently, the agency published a draft guidance providing more information on how sponsors...

Growing Market Size – US Clinical Trials Supply & Logistics

As per a study conducted in May 2024, the US clinical trials supply and logistics market size was placed at $1.90 billion in 2023...

Clinical Research Ecosystem Making Utmost Gene Therapy Use?

It is a well-established fact that gene therapy research happens to be booming. Since the U.S. Food and Drug Administration- FDA issued its first...

The Clinical Trial Participation Added More Seamlessness

Verified Clinical Trials is all set to integrate its research participation verification tools with the clinical trial automation platform of ProofPilot in a new...

Clinical Trials Automation: Step Towards Sustainable Pharma

The pharmaceutical sector is looking for certain transformative strategies so as to stay ahead in an era that is marked by fast technological growth...

Digital Innovation In Therapeutics For Faster Market Access

Right from finding potential active substances as well as identifying novel targets to simulating how drugs will perform within the human body and also...

CAR-NK Cell Therapy Trial Long-Term Findings Get Revealed

In a recent development, researchers from the US have gone on to report some promising outcomes out of a Phase I/II trial when it...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...